X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
index medicus (40) 40
hiv-2-infected patients (38) 38
hiv infections - virology (37) 37
infectious diseases (30) 30
virology (28) 28
hiv-2 (27) 27
west-africa (27) 27
immunodeficiency-virus type-2 (25) 25
hiv (23) 23
female (22) 22
viral load (22) 22
virus diseases (21) 21
adult (19) 19
hiv infections - drug therapy (19) 19
immunology (19) 19
hiv-2 - genetics (18) 18
hiv-2-infected individuals (18) 18
middle aged (18) 18
plasma viral load (18) 18
protease inhibitors (18) 18
in-vitro (17) 17
male (17) 17
hiv infection (16) 16
hiv-2 - drug effects (16) 16
antiretroviral therapy (15) 15
guinea-bissau (15) 15
hiv-2 - isolation & purification (14) 14
microbiology (14) 14
hiv infections - immunology (13) 13
hiv-2 - immunology (13) 13
research (13) 13
antiviral agents (12) 12
drug-resistance (12) 12
health aspects (12) 12
cd4 lymphocyte count (11) 11
hiv infections - epidemiology (11) 11
hiv-1 - immunology (11) 11
human-immunodeficiency-virus (11) 11
phenotypic susceptibility (11) 11
anti-hiv agents - therapeutic use (10) 10
hiv-1 (10) 10
mutation (10) 10
pharmacology & pharmacy (10) 10
senegal (10) 10
anti-hiv agents - pharmacology (9) 9
article (9) 9
disease progression (9) 9
epidemiology (9) 9
highly active antiretroviral therapy (9) 9
immunodeficiency-virus type-1 (9) 9
molecular sequence data (9) 9
reverse-transcriptase (9) 9
drug resistance (8) 8
drug therapy (8) 8
hiv-2 - classification (8) 8
human immunodeficiency virus--hiv (8) 8
infection (8) 8
reverse-transcriptase inhibitors (8) 8
aids (7) 7
cd8-positive t-lymphocytes - immunology (7) 7
cell line (7) 7
drug resistance, viral (7) 7
drug resistance, viral - genetics (7) 7
aged (6) 6
aids/hiv (6) 6
amino acid sequence (6) 6
cohort studies (6) 6
hiv-1 - isolation & purification (6) 6
hiv-2 - pathogenicity (6) 6
immune activation (6) 6
immunological response (6) 6
integrase inhibitors (6) 6
phylogeny (6) 6
proviral load (6) 6
t-cell responses (6) 6
to-child transmission (6) 6
viruses (6) 6
young adult (6) 6
acquired immune deficiency syndrome--aids (5) 5
adolescent (5) 5
analysis (5) 5
drug-resistance mutations (5) 5
hiv protease - genetics (5) 5
hiv protease inhibitors - pharmacology (5) 5
hiv-1 - genetics (5) 5
hiv-2 - enzymology (5) 5
human immunodeficiency virus (5) 5
infected-patients (5) 5
infections (5) 5
mutations (5) 5
therapy (5) 5
vitro phenotypic susceptibility (5) 5
acquired immune deficiency syndrome (4) 4
africa (4) 4
aids vaccines (4) 4
animals (4) 4
anti-retroviral agents - therapeutic use (4) 4
antiretroviral drugs (4) 4
cd4-positive t-lymphocytes - virology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 2/2009, Volume 48, Issue 4, pp. 476 - 783
Journal Article
Journal Article
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, ISSN 1525-4135, 06/2011, Volume 57, Issue 2, pp. 92 - 100
Background: Human gammadelta (gamma delta) T cells play an important role in protective immunity in HIV-1 and simian immunodeficiency virus infection; their... 
gammadelta T cell | HIV-1 | HIV-2-INFECTED INDIVIDUALS | VIRAL LOAD | V-DELTA | INFECTIOUS DISEASES | HIV-2 | Africa | RECEPTOR | IMMUNOLOGY | memory and effector phenotypes | RESPONSES | IN-VIVO | IMMUNE ACTIVATION | activation | MICROBIAL TRANSLOCATION | LYMPHOCYTES | BLOOD
Journal Article
HIV Medicine, ISSN 1464-2662, 07/2018, Volume 19, Issue 6, pp. 403 - 410
Journal Article
VIROLOGIE, ISSN 1267-8694, 09/2019, Volume 23, Issue 5, pp. 277 - 291
The HIV-2 virus is not widely spread worldwide, with only one to three million infected people, mainly in West Africa. HIV-2 is responsible for an attenuated... 
VIRAL LOAD | HIV-2-INFECTED INDIVIDUALS | LYMPHOTROPIC RETROVIRUS | LONG-TERM NONPROGRESSORS | HIV-2 | NEUTRALIZING ANTIBODY-RESPONSES | PROVIRAL DNA LOAD | epidemiology | physiopathology | T-CELL RESPONSES | VIROLOGY | virulence | IMMUNE ACTIVATION | IMMUNODEFICIENCY-VIRUS TYPE-2 | CORECEPTOR USAGE
Journal Article